- Report
- December 2024
- 52 Pages
United States
From €1064EUR$1,205USD£909GBP
- Report
- December 2024
- 72 Pages
United States
From €1064EUR$1,205USD£909GBP
- Report
- November 2024
- 50 Pages
United States
From €1064EUR$1,205USD£909GBP
- Report
- October 2024
- 71 Pages
United States
From €1064EUR$1,205USD£909GBP
- Report
- September 2024
- 73 Pages
United States
From €1064EUR$1,205USD£909GBP
- Report
- September 2024
- 30 Pages
United States
From €995EUR$1,207USD£880GBP
- Report
- September 2024
- 90 Pages
Africa, Middle East
From €2605EUR$2,950USD£2,225GBP
- Report
- September 2024
- 107 Pages
Asia Pacific
From €3047EUR$3,450USD£2,602GBP
- Report
- September 2024
- 111 Pages
Europe
From €3047EUR$3,450USD£2,602GBP
- Report
- September 2024
- 98 Pages
North America
From €2605EUR$2,950USD£2,225GBP
- Database
- June 2025
Global
From €265EUR$300USD£226GBP
- Report
- March 2023
- 296 Pages
Global
From €4238EUR$4,799USD£3,620GBP
- Report
- December 2022
- 40 Pages
United States
- Report
- April 2022
- 42 Pages
United States
- Report
- October 2021
- 66 Pages
United States
- Report
- May 2020
- 145 Pages
United States
€1232EUR$1,395USD£1,052GBP
- Report
- October 2022
- 185 Pages
Global
From €4238EUR$4,799USD£3,620GBP
- Report
- August 2022
- 214 Pages
Global
From €4238EUR$4,799USD£3,620GBP
- Report
- May 2022
- 231 Pages
Global
From €4238EUR$4,799USD£3,620GBP
- Report
- April 2022
- 552 Pages
Global
From €4238EUR$4,799USD£3,620GBP

The Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and commercialization of drugs and treatments for specific medical conditions. It is composed of a wide range of companies, from large multinationals to small start-ups, all of which are dedicated to researching and developing treatments for a variety of diseases and medical conditions. These companies are typically involved in the research and development of new drugs, as well as the marketing and distribution of existing drugs.
Some of the major players in the Therapeutic Area market include Pfizer, Merck, Novartis, GlaxoSmithKline, Sanofi, AstraZeneca, Johnson & Johnson, Bristol-Myers Squibb, and Eli Lilly. These companies are involved in the development of treatments for a variety of medical conditions, including cancer, cardiovascular disease, diabetes, and infectious diseases. Additionally, many of these companies are also involved in the development of treatments for rare diseases and orphan drugs. Show Less Read more